Diagnostic performance of the CellaVision preclassification neutrophil count – time to bypass the reclassification?
- 11 July 2024
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 84 (4) , 278-284
Abstract
The objective of this study was to perform a method comparison between the CellaVision preclassification neutrophil count and the reclassification neutrophil count performed by trained laboratory technicians, and to evaluate the diagnostic performance of the preclassification neutrophil count at clinical decision levels. We retrospectively identified patient samples through 2019-2022 in which the differential count was performed on Cellavision (n = 4,354). Data on sample characteristics and leukocyte- and differential counts was extracted from the electronic medical journal. For each sample, data containing the pre- and reclassification leukocyte classification, respectively, was extracted from the Cellavision software. Method comparison between the pre-and reclassification neutrophil count was performed using Bland Altman analysis. Diagnostic performance of the preclassification neutrophil count was evaluated according to four pre-specified categories of results with the reclassification as reference method. The median difference between the pre- and reclassification neutrophil count was 0.044 x 109/L. The preclassification neutrophil count categorised 95.6% of all samples correctly according to the four categories. The sensitivity, specificity, positive predictive value and negative predictive value for detecting neutrophilia > 7.00 x 109/L was 98.8%, 97.2%, 95.8%, and 99.2%, respectively. In samples with leukopenia (n = 543), the sensitivity, specificity, positive predictive value and negative predictive value for detecting severe neutropenia (< 0.50 x 109/L) was 97.7%, 99.1%, 98.6%, and 98.5%, respectively. The diagnostic performance of the CellaVision preclassification neutrophil count was satisfactory. The preclassification neutrophil count may be released to the electronic medical journal to improve turnaround time and benefit laboratory management.Keywords
Funding Information
- Simon Spies Fonden
This publication has 10 references indexed in Scilit:
- Management of febrile neutropaenia: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2016
- Performance of CellaVision DM96 in leukocyte classificationJournal of Pathology Informatics, 2013
- Absolute Neutrophil Counts From Automated Hematology Instruments Are Accurate and Precise Even at Very Low LevelsAmerican Journal of Clinical Pathology, 2012
- Experience with CellaVision DM96 for peripheral blood differentials in a large multi-center academic hospital systemJournal of Pathology Informatics, 2012
- Validation and Implementation of an Algorithm for Reporting the Automated Absolute Neutrophil Count From Selected Flagged SpecimensAmerican Journal of Clinical Pathology, 2010
- Can automated blood film analysis replace the manual differential? An evaluation of the CellaVision DM96 automated image analysis systemInternational Journal of Laboratory Hematology, 2009
- An algorithm for applying flagged Sysmex XE‐2100 absolute neutrophil counts in clinical practiceEuropean Journal of Haematology, 2008
- Performance Evaluation of the CellaVision DM96 SystemAmerican Journal of Clinical Pathology, 2005
- Peripheral blood film review: the demise of the eyecount leukocyte differentialClinics In Laboratory Medicine, 2002
- Measuring agreement in method comparison studiesStatistical Methods in Medical Research, 1999